The American Society of Transplantation have published consensus guidelines for the management of patients who receive solid organs from donors with HBV. Antiviral treatment reduces the rate of transmission in liver recipients from donors positive for HBV core antibodies and should be prescribed based on the recipient's immunity. Given the appropriate consent, the Society suggests that solid organs from donors who are positive for anti-HBV core antibodies should be considered for transplantation after individual assessment of the associated risks and benefits.